CEO Eren Bali said the company was winding down some of its COVID-19-related services and plans to shift its focus from growth to profitability.
Researchers found therapists with a higher percentage of clients from lower socioeconomic status groups, patients on Medicaid and families were less likely to keep using telehealth after the pandemic.
Also: Autism-focused SpectrumAi and cancer clinical trial platform Massive Bio both scooped up $9 million.
The investment will be used for its Asia-Pacific expansion while leveraging Metro's presence.
The company plans to use the funding to hire new team members and invest in its technology.
Also: Mental health chatbot Woebot Health brings on Moses Ike as the company's first chief financial officer, and digital neurotherapeutic maker MindMaze announces a slew of new leadership hires.
The AI platform can predict a person's risk of having a stroke or a heart attack in the next five years.
Rite Aid pharmacists will be able to send patients to Homeward for wellness visits, screenings and risk assessments.
